Rivipansel (GMI-1070)
Products Rivipansel is currently in clinical development at GlycoMimetics and Pfizer. The drug is not yet commercially available. Structure and properties Rivipansel (C58H74N6O31S3, Mr = 1447.4 g/mol) is a glycomimetic developed by the research group led by Prof. Beat Ernst at the Institute of Molecular Pharmacy, University of Basel, in collaboration with GlycoMimetics. Effects Rivipansel … Rivipansel (GMI-1070)
